Correlation Between CTT Pharmaceutical and HLS Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CTT Pharmaceutical and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTT Pharmaceutical and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTT Pharmaceutical Holdings and HLS Therapeutics, you can compare the effects of market volatilities on CTT Pharmaceutical and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTT Pharmaceutical with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTT Pharmaceutical and HLS Therapeutics.

Diversification Opportunities for CTT Pharmaceutical and HLS Therapeutics

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between CTT and HLS is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding CTT Pharmaceutical Holdings and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and CTT Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTT Pharmaceutical Holdings are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of CTT Pharmaceutical i.e., CTT Pharmaceutical and HLS Therapeutics go up and down completely randomly.

Pair Corralation between CTT Pharmaceutical and HLS Therapeutics

Given the investment horizon of 90 days CTT Pharmaceutical Holdings is expected to generate 5.37 times more return on investment than HLS Therapeutics. However, CTT Pharmaceutical is 5.37 times more volatile than HLS Therapeutics. It trades about 0.06 of its potential returns per unit of risk. HLS Therapeutics is currently generating about 0.05 per unit of risk. If you would invest  6.83  in CTT Pharmaceutical Holdings on December 3, 2024 and sell it today you would lose (0.62) from holding CTT Pharmaceutical Holdings or give up 9.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy85.0%
ValuesDaily Returns

CTT Pharmaceutical Holdings  vs.  HLS Therapeutics

 Performance 
       Timeline  
CTT Pharmaceutical 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, CTT Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.
HLS Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

CTT Pharmaceutical and HLS Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CTT Pharmaceutical and HLS Therapeutics

The main advantage of trading using opposite CTT Pharmaceutical and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTT Pharmaceutical position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.
The idea behind CTT Pharmaceutical Holdings and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories